Amy Colcher

Amy Colcher

Neurology
3740 West Chester Pike
Newtown Square, PA 19073

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment with Steroids and Intravenous Immunoglobulin: A Case Presentation and Literature Review.

Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment with Steroids and Intravenous Immunoglobulin: A Case Presentation and Literature Review.

Journal: Cureus
Published: August 15, 2019

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Journal: JAMA neurology
Published: July 11, 2017

Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.

Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.

Journal: Movement disorders clinical practice
Published: October 07, 2016

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Journal: JAMA
Published: July 06, 2016

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

Journal: Neurology
Published: March 22, 2016

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Journal: JAMA neurology
Published: May 24, 2013

Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.

Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: December 20, 2012

Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease.

Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 22, 2012

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

Journal: Journal of the neurological sciences
Published: August 29, 2012

Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.

Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 27, 2012

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Journal: Neurology
Published: March 24, 2012

Genetic influences on cognitive decline in Parkinson's disease.

Genetic influences on cognitive decline in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 10, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026